Gambia vs Ghana: Meningococcal A conjugate (MENGA) vaccine immunization coverage (%)
Gambia
82.0%
in 2025
Ghana
91.0%
in 2025
Gambia rank
3rd
Ghana rank
1st
Meningococcal A conjugate (MENGA) vaccine immunization coverage (%) over time
- Gambia
- Ghana
How they compare
Ghana currently reports 91.0% against 82.0% in Gambia, a difference of 9.0%.
That makes Ghana's figure about 1.1 times Gambia's.
The two have swapped places 2 times across 10 shared years of data; in 2016 it was Ghana ahead.
Gambia ranks 3rd and Ghana ranks 1st of 26 countries.
Ghana has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Gambia | Ghana | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 8.8% | 64.2% | 55.5% | Ghana |
| 2020s | 75.3% | 82.5% | 7.2% | Ghana |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher meningococcal a conjugate (menga) vaccine immunization coverage (%), Gambia or Ghana?
- Ghana, at 91.0% against 82.0% in Gambia as of 2025.
- What is the difference in meningococcal a conjugate (menga) vaccine immunization coverage (%) between Gambia and Ghana?
- 9.0%, with Ghana ahead.
- How many years of comparable data are there for Gambia and Ghana?
- 10 years are reported by both, from 2016 to 2025.
- How do Gambia and Ghana rank globally for meningococcal a conjugate (menga) vaccine immunization coverage (%)?
- Gambia ranks 3rd and Ghana ranks 1st of 26 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Meningococcal A conjugate (MENGA) vaccine immunization coverage (%) (WUENIC). Statizoid refreshes it automatically from the source and publishes the full history for both places.